High-frequency cell surface expression of a foreign protein in murine hematopoietic stem cells using a new retroviral vector

Blood

Volumn 87, Issue 2, 1996, Pages 509-517

  Tumas, Daniel B ^b   Spangrude, Gerald J ^b   Brooks, Diane M ^b   Williams, C Dirk ^b   Chesebro, Bruce ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; FLUOROURACIL;

ANIMAL CELL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL PROLIFERATION; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL; MITOSIS RATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RETROVIRUS; VIRUS DNA CELL DNA INTERACTION;

EID: 0030048886     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.2.509.bloodjournal872509     Document Type: Article

References (52)

1. Mulligan RC: The basic science of gene therapy. Science 260:926, 1993
2. Karlsson S: Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood 78:2481, 1991
3. Miller AD: Human gene therapy comes of age Nature 357:455, 1992
4. Sorrentino BP, Brandt SJ, Bodine D, Gottesman M, Pastan I, Cline A, Nienhuis AW: Selection of drug resistant bone marrow cells in vivo after retroviral transfer of human MDRI. Science 257:99, 1992
5. Lim B, Apperley JF, Orkin SH, Williams DA: Long-term expression of human adenosine deaminase in mice transplanted with retrovirus-infected hematopoietic stem cells. Proc Natl Acad Sci USA 86:8892, 1989
6. Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980, 1989
7. Friend C: Cell-free transmission of in adult Swiss mice of a disease having the character of a leukemia J Exp Med 105:307, 1957
8. Steeves RA: Spleen-focus-forming virus in Friend and Rauscher leukemia virus preparations. J Natl Cancer Inst 54:289, 1975
9. Ruscetti S, Davis L, Feild J, Oliff A: Friend murine leukemia virus-induced leukemia is associated with the formation of mink cell focus-inducing viruses and is blocked in mice expressing endogenous, mink cell focus-inducing xenotropic viral envelope genes. J Exp Med 154:907, 1981
10. Bestwick RK, Hankins WD, Kabat D: Roles of helper and defective retroviral genomes in murine erythroleukemia: Studies of spleen focus-forming virus in the absence of helper. J Virol 56:660, 1985
11. Ben-David Y, Bernstein A: Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell 66:831, 1991
12. Longmore GD, Pharr P, Neumann D, Lodish HF: Both megakaryocytopoiesis and erythropoiesis are induced in mice infected with a retrovirus expressing an oncogenic erythropoietin receptor. Blood 82:2386, 1993
13. Pharr PN, Hankins D, Hofbauer A, Lodish HF, Longmore GD: Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth. Proc Natl Acad Sci USA 90:938, 1993
14. Holland CA, Anklesaria P, Sakakeeny MA, Greenberger JS: Enhancer sequences of a retroviral vector determine expression of a gene in multipotent hematopoietic progenitors and committed erythroid cells. Proc Natl Acad Sci USA 84:8662, 1987
15. Bestwick RK, Kozak SL, Kabat D: Overcoming interference to retroviral superinfection results in amplified expression and transmission of cloned genes. Proc Natl Acad Sci USA 85:5404, 1988
16. Kabat D, Kozak SL, Wehrly K, Chesebro B: Differences in CD4 dependence for infectivity of laboratory adapted and primary patient isolates of human immunodeficiency virus type 1. J Virol 68:2570, 1994
17. Chesebro B, Wehrly K, Caughey B, Nishio J, Ernst D, Race R: Foreign PrP expression and scrapie infection in tissue culture cell lines. Dev Biol Stand 80:131, 1993
18. Priola SA, Caughy B, Race RE, Chesebro B: Heterologous PrP molecules molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J Virol 68:4873, 1994
19. Spiro C, Li JP, Bestwick RK, Kabat D: An enhancer sequence instability that diversifies the cell repetoire for expresion of a murine leukemia virus. Virology 164:350, 1988
20. Shen F-W: Monoclonal antibodies to mouse lymphocyte differentiation antigens, in Hammerling GJ, Hammerling U, Kearney JF (eds): Monoclonal Antibodies and T-Cell Hybridomas, vol I. Amsterdam, The Netherlands, Elsevier/North Holland Biomedical Press, 1981, p 25
21. Spangrude GJ, Brooks DM, Tumas DB: Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: In vivo expansion of stem cell phenotype but not function. Blood 85:1006, 1995
22. Spangrude GJ, Heimfeld S, Weissman IL: Purification and characterization of mouse hematopoietic stem cells. Science 241:58, 1988
23. Spangrude GJ, Smith L, Uchida N, Ikuta K, Heimfeld S, Friedman J, Weissman IL: Mouse hematopoietic stem cells. Blood 78.1395, 1991
24. Szilvassy SJ, Cory S: Phenotypic and functional characterization of competitive long-term repopulating hematopoietic stem cells enriched from 5-fluorouracil-treated murine marrow. Blood 81:2310, 1993
25. Spangrude GJ, Brooks DM: Phenotypic analysis of mouse hematopoietic stem cells shows a Thy-1-negative subset. Blood 80:1957, 1992
26. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Spangrude GJ, Weissman IL: Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol 122 847, 1993
27. Li JP, Bestwick RK, Spiro CS, Kabat D: The membrane glycoprotein of Friend spleen focus forming virus: Evidence that the cell surface component is required for pathogenesis and that it binds to a receptor. J Virol 61:2782, 1987
28. Bolton DC, Seligman SJ, Bablanian G, Windsor D, Scala LJ, Kim KS, Chen CM, Kascsak RJ, Bendheim PE: Molecular location of a species-specific epitope on the hamster scrapie agent protein J Virol 65:3667, 1991
29. Miller AD, Buttimore C: Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895, 1986
30. Mann R, Mulligan RC, Baltimore D: Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33:153, 1983
31. Robertson MN, Spangrude GJ, Hasenkrug K, Perry L, Nishio J, Wehrly K, Chesebro B: The role and specificity of T-cell subsets in spontaneous recovery form Friend virus-induced leukemia in mice J Virol 66:3271, 1992
32. Kozak SL, Kabat D: Ping-pong amplification of a retroviral vector achieves high-level gene expression: Human growth hormone production. J Virol 64:3500, 1990
33. Chesebro B, Wehrly K: Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity J Virol 62:3779, 1988
34. Sitbon M, Nishio J, Wehrly K, Lodmell D, Chesebro B: Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: Distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses. Virology 141:110, 1985
35. Lemishka IR, Raulet DH, Mulligan RC: Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 45:917, 1986
36. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239, 1990
37. Harrison DE, Lerner CP: Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. Blood 78.1237, 1991
38. Bodine DM, McDonagh KT, Seidel NE, Nienhuis AW: Survival and retrovirus infection of murine hematopoietic stem cells in vitro: Effects of 5-FU and method of infection. Exp Hematol 19:206, 1991
39. Hajihosseini M, Iavachev L, Price J: Evidence that retroviruses integrate into post-replication host DNA. EMBO J 12:4969, 1993
40. + hematopoietic stem cells. Blood 83:3758, 1994
41. Smith LG, Weissman IL, Heimfeld S: Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc Natl Acad Sci USA 88:2788, 1991
42. + cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow. J Exp Med 175:175, 1992
43. Sitbon M, Ellerbrok H, Pozo F, Nishio J, Hayes SF, Evans LH, Chesebro B: Sequences in the U5-gag-pol region influence early and late pathogenic effects of Friend and Moloney murine leukemia viruses. J Virol 64:2135, 1990
44. v mice Cell 42:71, 1985
45. Vile RG, Russell SJ: Retroviruses as vectors. Br Med Bull 51:12, 1995
46. Richards CA, Huber BE: Generation of a transgenic model for retrovirus-mediated gene therapy for hepatocellular carcinoma is thwarted by the lack of transgene expression. Hum Gene Ther 4:143, 1993
47. Lerner C, Harrison DE: 5-Fluorouracil spares hematopoietic stem cells responsible for long-term repopulation. Exp Hematol 18:114, 1990
48. Mavilio F, Ferrari G, Rossini S, Nobili N, Bonini C, Casorati G, Traversari C, Bordignon C: Peripheral blood lymphocytes as targets of retroviral vector-mediated gene transfer. Blood 83:1988, 1994
49. Pawliuk R, Kay R, Lansdorp P, Humphries RK: Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer. Blood 84:2868, 1994
50. Strair RK, Towle MJ, Smith BR: Recombinant retroviruses encoding cell surface antigens as selectable markers. J Virol 62:4756, 1988
51. Podda S, Ward M, Himelstein A, Richardson C, De La Flor-Weiss E, Smith L, Gottesman M, Pastan I, Bank A: Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci USA 89:9676, 1992
52. Bonini C, Verzeletti S, Servida P, Rossini S, Traversari C, Ferrari G, Nobili N, Mavilio F, Bordignon C: Transfer of the HSV-TK gene into donor peripheral blood lymphocytes for in vivo immunomodulation of donor antitumor immunity after allo-BMT. Blood 84:110a, 1994 (abstr, suppl 1)